(Q40063650)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Michele L Scotti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Seth Tomblyn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alison E B Springs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wen Y Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

23 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

241-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17955362%20AND%20SRC:MED&resulttype=core&format=json

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9789-Z

Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9789-Z

The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9789-Z

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9789-Z

Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9789-Z